The cost of cracking cancer: what the $1tn race for a cure leaves behindThe first in an FT series looking at the new energy behind the fight for cancer curesThe Covid-era tech that could reinvent cancer carePandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncologyPricy new cancer drugs offer patients hope but pile pressure on health budgetsMedical breakthroughs come with spiralling price tag, leaving policymakers with tough decisions
The cost of cracking cancer: what the $1tn race for a cure leaves behindThe first in an FT series looking at the new energy behind the fight for cancer curesThe Covid-era tech that could reinvent cancer carePandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncologyPricy new cancer drugs offer patients hope but pile pressure on health budgetsMedical breakthroughs come with spiralling price tag, leaving policymakers with tough decisions
